Z variant heterozygosity in alpha-1 antitrypsin deficiency: disease risk and treatment implications

By afschroeder • April 9, 2026

Hersh CP, Teckman JH, Strnad P, Hakim A, Carroll TP, Hall IP, Ghosh AJ, Barjaktarevic I, McElvaney NG, Kaserman JE, Lomas DA, Strange C, Drummond MB, Rennard S, Hanna KE, Clark VC, Goldklang MP, Iverson P, Wilson AA. Z variant heterozygosity in alpha-1 antitrypsin deficiency: disease risk and treatment implications. Orphanet J Rare Dis. 2026 Apr 8;21(1):136. doi: 10.1186/s13023-026-04283-9. PMID: 41952152.

Tags: alpha-1 antitrypsin, alpha-1 antitrypsin deficiency, Augmentation therapy, Carrier state, chronic liver disease, COPD, Heterozygote, Publications, Pulmonary, Critical Care & Sleep Medicine, rare disease

Could School Function Be an Adolescent Health Vital Sign? Associations Between Gradebook Data and Substance Use Among Middle School Students

DiPentino R, Meza BPL, Jackson N, Dosanjh KK, Dudovitz RN, Wong MD. Could School Function Be an Adolescent Health Vital Sign? Associations Between Gradebook Data[...]

Yellow Fever Reemergence in Tolima, Colombia 2024-2025: An Eco-epidemiological Study

Judson SD, Stephan N, Machuca S, Henao-Martínez AF, Parra-Henao G, Vivas R, Alarcón-Robayo JF, Vera Soto MJ, Vargas H. Yellow Fever Reemergence in Tolima, Colombia[...]

Safety and Efficacy of the Ahmed ClearPath versus Ahmed ClearPath Small Tube at Six Months: A Retrospective Comparative Cohort Study

Shi KSY, Dorairaj EA, Bhartiya S, Oyama K, Wang W, Thé RY, Moreno KB, Wang M, Towne C, Qozat IM, Banoub RG, Dorairaj SK. Safety[...]